Search - tctmd.com

Displaying 241 - 260 of 378

Sort: Relevancy | Date

Presentation TCT 2014

Watchman Nightmare Case and Teaching Moment #2: Improper Device Sizing with Embolization

Presenter: Josep Rodés-Cabau, Carlos E. Ruiz, Vivek Y. Reddy

September 13, 2014

Presentation TCT 2014

Watchman Nightmare Case and Teaching Moment #1: A Perforation

Presenter: Josep Rodés-Cabau, Carlos E. Ruiz, Maurice Buchbinder

September 13, 2014

Presentation TCT 2014

LAA Closure with the Watchman Device: A Perfect Case (Step-by-Step)

Presenter: Josep Rodés-Cabau, Carlos E. Ruiz, Ramon Quesada

September 13, 2014

Presentation TCT 2014

Preprocedure Groundwork: Imaging the LAA and Device Selection

Presenter: Josep Rodés-Cabau, Carlos E. Ruiz

September 13, 2014

Presentation TCT 2014

Hemodynamic and Patient-Care Concerns When Accessing the Left Atrium

Presenter: Marsha Holton, John R. Zimmerman, Jeff Davis

September 13, 2014

Presentation TCT 2014

Fundamental Knowledge: Left Atrial Appendage Anatomy, Function, and Relational Pathology

Presenter: Marsha Holton, John R. Zimmerman, Brij Maini

September 13, 2014

News Daily News

研究发现，应当仅对风险最高的患者使用勒除器进行LAA封堵

Yael L. Maxwell

August 07, 2014

News Daily News

Study Indicates Snare Device for LAA Closure Should Only Be Used in Highest-Risk Patients

Yael L. Maxwell

August 07, 2014

News Daily News

Según Estudio un Dispositivo Cepo para el Cierre del AAI Solo debería de Usarse en los Pacientes de Más Alto Riesgo

Yael L. Maxwell

August 07, 2014

News Daily News

PREVAIL Published: Watchman, Warfarin Show Comparable Stroke Protection in A-fib

July 03, 2014

News Daily News

PREVAIL Publicado: Watchman y Warfarina Ofrecen Protección Similar Frente a los ACV en Pacientes con FA

July 03, 2014

Presentation TCT 2013

LAA Exclusion for Patients with Atrial Fibrillation: Appropriate Indications, Concerns, and Unanswered Questions

Presenter: Reda Ibrahim

October 31, 2013

Presentation TCT 2013

Complex Congenital Heart Disease Intervention: Year in Review

Presenter: Frank Ing

October 31, 2013

Presentation TCT 2013

The Common Dilemma of Managing Operator Learning Curve Issues and Evolving Clinical Trial Considerations (eg, Control Populations, Clinical Indications, and Optimal Endpoints)

Presenter: Ted Feldman

October 30, 2013

Presentation TCT 2013

Practical and Meaningful Clinical Trial Pathways for New Mitral Valve Therapies

Presenter: Paul Grayburn

October 30, 2013

Presentation TCT 2013

For Left Atrial Appendage Occlusion

Presenter: Brian Whisenant

October 30, 2013

Presentation TCT 2013

Clinical Trial Alternatives for New LAA Occlusion Devices: For High-Risk AF Patients Who Are Tolerant to Anticoagulation or Poor Anticoagulation Candidates Due to Bleeding Risks...

Presenter: Brian Whisenant

October 30, 2013

News Conference News TCT 2013

Debate Leaves Little Doubt of LAA Closure Efficacy in the Prevention of Stroke in AF Patients

October 30, 2013

Presentation TCT 2013

Safety and Early Efficacy of the Lariat Procedure: Results from the U.S. Transcatheter LAA Ligation Consortium

Presenter: Matthew J. Price

October 29, 2013

Presentation TCT 2013

Long term follow up of 134 patients with non valvular atrial fibrillation and contraindications to oral anticoagulation therapy, treated with the Ampatzer Cardiac Plug Device for LAA

Presenter: Miroslava Stolcova

October 29, 2013

Advertisement

Watchman Nightmare Case and Teaching Moment #2: Improper Device Sizing with Embolization

Watchman Nightmare Case and Teaching Moment #1: A Perforation

LAA Closure with the Watchman Device: A Perfect Case (Step-by-Step)

Preprocedure Groundwork: Imaging the LAA and Device Selection

Hemodynamic and Patient-Care Concerns When Accessing the Left Atrium

Fundamental Knowledge: Left Atrial Appendage Anatomy, Function, and Relational Pathology

研究发现，应当仅对风险最高的患者使用勒除器进行LAA封堵

Study Indicates Snare Device for LAA Closure Should Only Be Used in Highest-Risk Patients

Según Estudio un Dispositivo Cepo para el Cierre del AAI Solo debería de Usarse en los Pacientes de Más Alto Riesgo

PREVAIL Published: Watchman, Warfarin Show Comparable Stroke Protection in A-fib

PREVAIL Publicado: Watchman y Warfarina Ofrecen Protección Similar Frente a los ACV en Pacientes con FA

LAA Exclusion for Patients with Atrial Fibrillation: Appropriate Indications, Concerns, and Unanswered Questions

Complex Congenital Heart Disease Intervention: Year in Review

The Common Dilemma of Managing Operator Learning Curve Issues and Evolving Clinical Trial Considerations (eg, Control Populations, Clinical Indications, and Optimal Endpoints)

Practical and Meaningful Clinical Trial Pathways for New Mitral Valve Therapies

For Left Atrial Appendage Occlusion

Clinical Trial Alternatives for New LAA Occlusion Devices: For High-Risk AF Patients Who Are Tolerant to Anticoagulation or Poor Anticoagulation Candidates Due to Bleeding Risks...

Debate Leaves Little Doubt of LAA Closure Efficacy in the Prevention of Stroke in AF Patients

Safety and Early Efficacy of the Lariat Procedure: Results from the U.S. Transcatheter LAA Ligation Consortium

Long term follow up of 134 patients with non valvular atrial fibrillation and contraindications to oral anticoagulation therapy, treated with the Ampatzer Cardiac Plug Device for LAA

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content